Schroder Investment Management Group Edwards Lifesciences Corp Transaction History

Schroder Investment Management Group

  • $101 Billion
  • Q4 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$72.54 - $95.56 $47.1 Million - $62.1 Million
649,980 New
649,980 $62.1 Million
Q4 2022

Feb 10, 2023
SELL
$68.3 - $87.44 $18.6 Million - $23.8 Million
-272,134 Reduced 34.36%
519,916 $38.8 Million
Q3 2022

Nov 10, 2022
SELL
$82.37 - $107.29 $161 Million - $209 Million
-1,949,897 Reduced 71.11%
792,050 $65.4 Million
Q2 2022

Aug 11, 2022
SELL
$86.5 - $128.27 $12.8 Million - $19 Million
-148,319 Reduced 5.13%
2,741,947 $261 Million
Q1 2022

May 16, 2022
BUY
$101.96 - $128.34 $549,870 - $692,137
5,393 Added 0.19%
2,890,266 $338 Million
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $67 Million - $82.3 Million
629,868 Added 27.93%
2,884,873 $374 Million
Q3 2021

Nov 12, 2021
SELL
$102.91 - $122.75 $4.77 Million - $5.7 Million
-46,399 Reduced 2.02%
2,255,005 $255 Million
Q2 2021

Aug 13, 2021
BUY
$83.84 - $104.76 $26.6 Million - $33.2 Million
317,053 Added 15.98%
2,301,404 $238 Million
Q1 2021

May 17, 2021
SELL
$78.68 - $90.67 $20.6 Million - $23.7 Million
-261,566 Reduced 11.65%
1,984,351 $166 Million
Q4 2020

Feb 16, 2021
SELL
$71.69 - $91.23 $14.6 Million - $18.5 Million
-203,116 Reduced 8.29%
2,245,917 $205 Million
Q3 2020

Nov 13, 2020
BUY
$67.19 - $87.44 $97 Million - $126 Million
1,443,976 Added 143.67%
2,449,033 $193 Million
Q2 2020

Aug 13, 2020
BUY
$57.54 - $76.95 $50.6 Million - $67.7 Million
880,188 Added 704.89%
1,005,057 $69.5 Million
Q1 2020

May 15, 2020
SELL
$52.41 - $81.0 $1.19 Million - $1.84 Million
-22,746 Reduced 15.41%
124,869 $24.4 Million
Q4 2019

Feb 11, 2020
BUY
$71.7 - $82.09 $8.04 Million - $9.2 Million
112,070 Added 315.29%
147,615 $34.4 Million
Q3 2019

Nov 12, 2019
SELL
$61.55 - $75.43 $161,014 - $197,324
-2,616 Reduced 6.86%
35,545 $7.72 Million
Q2 2019

Aug 08, 2019
BUY
$55.74 - $64.41 $1.12 Million - $1.3 Million
20,163 Added 112.03%
38,161 $7.05 Million
Q1 2019

May 14, 2019
SELL
$47.89 - $64.05 $28,829 - $38,558
-602 Reduced 3.24%
17,998 $3.44 Million
Q4 2018

Feb 14, 2019
SELL
$46.41 - $56.94 $611,590 - $750,355
-13,178 Reduced 41.47%
18,600 $2.85 Million
Q3 2018

Nov 13, 2018
SELL
$45.7 - $58.03 $530,577 - $673,728
-11,610 Reduced 26.76%
31,778 $5.53 Million
Q2 2018

Aug 13, 2018
SELL
$42.45 - $51.3 $618,538 - $747,492
-14,571 Reduced 25.14%
43,388 $6.37 Million
Q1 2018

May 11, 2018
SELL
$37.19 - $47.45 $3.76 Million - $4.79 Million
-101,045 Reduced 63.55%
57,959 $8.09 Million
Q4 2017

Feb 09, 2018
BUY
$33.79 - $39.39 $1.14 Million - $1.32 Million
33,600 Added 26.79%
159,004 $17.9 Million
Q3 2017

Nov 09, 2017
BUY
$36.29 - $38.83 $4.55 Million - $4.87 Million
125,404
125,404 $13.7 Million

Others Institutions Holding EW

# of Institutions
1,383
Shares Held
487M
Call Options Held
6.71M
Put Options Held
3.17M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email